Showing results (221-230 of 432) with videos related to
Sort By:
Pageof 44
The Lancet. Infectious Diseases|June 9, 2014
Switching to coformulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus continuation of non-nucleoside reverse transcriptase inhibitor with emtricitabine and tenofovir in virologically suppressed adults with HIV (STRATEGY-NNRTI): 48 week results of a randomised, open-label, phase 3b non-inferiority trialAnton Pozniak, Martin Markowitz, Anthony Mills, et al.Frontiers in Medicine|September 28, 2020
Pulmonary Thrombosis or Embolism in a Large Cohort of Hospitalized Patients With Covid-19Natividad Benito, David Filella, Jose Mateo, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 19, 2002
Severe nucleoside-associated lactic acidosis in human immunodeficiency virus-infected patients: report of 12 cases and review of the literatureVicente Falcó, Dolors Rodríguez, Esteban Ribera, et al.AIDS (London, England)|August 17, 2005
Genotypic and phenotypic resistance patterns at virological failure in a simplification trial with nevirapine, efavirenz or abacavirAnna Ochoa de Echagüen, Mireia Arnedo, Mariona Xercavins, et al.AIDS (London, England)|August 6, 2015
Clinical value of ultradeep HIV-1 genotyping and tropism testing in late presenters with advanced diseaseMaria Casadellà, Christian Manzardo, Marc Noguera-Julian, et al.Scientific Reports|March 26, 2025
Omics for searching plasma biomarkers associated with unfavorable COVID-19 progression in hypertensive patientsAlba Sánchez, Graciano García-Pardo, Anna Martí, et al.Drug and Alcohol Dependence|April 8, 2006
Polymorphisms of alcohol-metabolizing enzymes and the risk for alcoholism and alcoholic liver disease in Caucasian Spanish womenAlfons Lorenzo, Teresa Auguet, Francesc Vidal, et al.Emerging Infectious Diseases|July 14, 2011
Association of Patients' Geographic Origins with Viral Hepatitis Co-infection Patterns, SpainSantiago Pérez Cachafeiro, Ana María Caro-Murillo, Juan Berenguer, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 8, 2006
Discontinuation of primary and secondary Toxoplasma gondii prophylaxis is safe in HIV-infected patients after immunological restoration with highly active antiretroviral therapy: results of an open, randomized, multicenter clinical trialJose M Miro, Juan C Lopez, Daniel Podzamczer, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|October 5, 2013
Peak bone mass in young HIV-infected patients compared with healthy controlsEugènia Negredo, Pere Domingo, Elena Ferrer, et al.Pageof 44